Assessment of Tremor Using SNUMAP Motion Sensing System
SNUMAP
Quantitative Assessment of Tremor Using Portable Six-axis (Tri-axial Accelerometer and Tri-axial Gyroscope) Motion Sensing System
1 other identifier
interventional
187
1 country
1
Brief Summary
The purpose of this study is to record and measure tremor using portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2014
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2012
CompletedFirst Posted
Study publicly available on registry
November 21, 2012
CompletedStudy Start
First participant enrolled
August 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2015
CompletedJuly 8, 2015
July 1, 2015
6 months
November 15, 2012
July 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
3-D Accelerometric and gyroscope variables measured
Correlation between SNUMAP motion sensing system symptom assessment and clinical tremor rating scale (TRS) scores
1 day
Study Arms (1)
SNUMAP assessment
EXPERIMENTALUses SNUMAP motion sensing system to quantify tremor symptom.
Interventions
Portable six-axis (tri-axial accelerometer and tri-axial gyroscope) motion sensing system
Eligibility Criteria
You may qualify if:
- Age: 20-80 years
- Patients with tremor (involuntary, rhythmic, oscillatory movement in one or more body part)
- Subject who signed an informed consent
You may not qualify if:
- Pregnant or nursing woman.
- Comorbid neurologic illnesses that impact the ability to perform the study tasks.
- Subjects with medical condition that in the opinion of the investigator would affect his/her ability to participate in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Life Science Technology Inc.collaborator
Study Sites (1)
Department of Neurology, Seoul National University Hospital
Seoul, 110-744, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Beom S Jeon, M.D., Ph.D.
Seoul National University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Chairman, Department of Neurology
Study Record Dates
First Submitted
November 15, 2012
First Posted
November 21, 2012
Study Start
August 1, 2014
Primary Completion
February 1, 2015
Study Completion
February 1, 2015
Last Updated
July 8, 2015
Record last verified: 2015-07